Press Room

Quanticate's Principal Programmer, Will Greenway, will host a speaker session on Define.xml at the CDISC Interchange Berlin on the 26th April!

Quanticate will be exhibiting at the ACDM 2018 Annual Conference,  March 13th at the Radisson Blue Hotel, Brussels, Stand #9.

Quanticate will be exhibiting at the Outsourcing in Clinical Trials (OCT) 2018,  February 21st-22nd, Burlingame at the Hayatt Regency San Francisco Airport Hotel, booth #9

Quanticate, a data-focused clinical research organisation (CRO), has launched its centralised statistical monitoring service as an extension of its statistical consultancy offering in response to recent amendments to the International Conference of Harmonisation (ICH) Good Clinical Practice (GCP) E6(R2) guidelines.

Quanticate will be exhibiting at the Partnerships in Clinical Trials (PCT) 2017,  November 28th - 29th, Amsterdam. Meet us at the RAI Amsterdam Convention Center at stand #19.

Quanticate will be exhibiting at the PhUSE Annual Conference  2017, October 8th-11th, 2017, Edinburgh, Scotland. Meet us at Edinburgh International Conference Centre at booth #43

Quanticate, a global data-focused clinical research organisation (CRO), is further expanding its service offering into India with the opening of a new office.

Strategically located in Bangalore, with access to the country’s extensive talent pool in the pharmaceutical services industry, the new office will be a base from which Quanticate will broaden its capabilities for the management, analysis and reporting of data from clinical trials and post-marketing surveillance.

Quanticate will be exhibiting at the OCT New England 2017 Conference, September 6th-7th, 2017, Boston, MA. Meet us at the Westin Boston Waterfront stand #001

During May 2017, the European Commission and EMA published a Notice to marketing authorisation holders of centrally authorised medicines products for human and veterinary use, stating: “The United Kingdom submitted on 29 March 2017 the notification of its intention to withdraw from the Union pursuant to Article 50 of the Treaty on European Union. This means that unless the withdrawal agreement establishes another date or the period is extended by the European Council in accordance with Article 50(3) of the Treaty on European Union, all Union primary and secondary law ceases to apply to the United Kingdom from 30 March 2019, 00:00h (CET). The United Kingdom will then become a 'third country'.”

Quanticate has completed an investment initiative to upgrade its pharmacovigilance safety database and its in-house technology platform in preparation for the upcoming Article 2(3) of Directive 2010/84/EU that will impact the pharmaceutical industry later this year.